Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan C Fagan

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Stroke|September 6, 2014
Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidenceDenise M Boudreau, Gregory F Guzauskas, Er Chen, et al.
Neurochemistry International|June 10, 2022
Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental strokeAbdelrahman Y Fouda, Heba A Ahmed, Bindu Pillai, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 2, 2019
Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot studyWael Eldahshan, Tauheed Ishrat, Bindu Pillai, et al.
Pharmacological Research|March 1, 2019
NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemiaRebecca Ward, Weiguo Li, Yasir Abdul, et al.
Life (Basel, Switzerland)|June 28, 2023
Stimulation of Angiotensin II Type 2 Receptor Modulates Pro-Inflammatory Response in Microglia and Macrophages: Therapeutic Implications for the Treatment of StrokeAbdulkarim Alshammari, Yohan Han, Timothy W Jones, et al.
Molecular Neurobiology|January 14, 2016
Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental StrokeAbdelrahman Y Fouda, Ahmed Alhusban, Tauheed Ishrat, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 15, 2018
Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic strokeTauheed Ishrat, Abdelrahman Y Fouda, Bindu Pillai, et al.
Molecular Neurobiology|August 3, 2014
Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in ratsTauheed Ishrat, Bindu Pillai, Sahar Soliman, et al.
Processes (Basel, Switzerland)|May 6, 2021
Overview and Update on Methods for Cargo Loading into Extracellular VesiclesYohan Han, Timothy W Jones, Saugata Dutta, et al.
Stroke Research and Treatment|August 23, 2014
Role of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonismTauheed Ishrat, Anna Kozak, Ahmed Alhusban, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Stroke|September 6, 2014
Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidenceDenise M Boudreau, Gregory F Guzauskas, Er Chen, et al.
Neurochemistry International|June 10, 2022
Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental strokeAbdelrahman Y Fouda, Heba A Ahmed, Bindu Pillai, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 2, 2019
Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot studyWael Eldahshan, Tauheed Ishrat, Bindu Pillai, et al.
Pharmacological Research|March 1, 2019
NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemiaRebecca Ward, Weiguo Li, Yasir Abdul, et al.
Life (Basel, Switzerland)|June 28, 2023
Stimulation of Angiotensin II Type 2 Receptor Modulates Pro-Inflammatory Response in Microglia and Macrophages: Therapeutic Implications for the Treatment of StrokeAbdulkarim Alshammari, Yohan Han, Timothy W Jones, et al.
Molecular Neurobiology|January 14, 2016
Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental StrokeAbdelrahman Y Fouda, Ahmed Alhusban, Tauheed Ishrat, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 15, 2018
Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic strokeTauheed Ishrat, Abdelrahman Y Fouda, Bindu Pillai, et al.
Molecular Neurobiology|August 3, 2014
Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in ratsTauheed Ishrat, Bindu Pillai, Sahar Soliman, et al.
Processes (Basel, Switzerland)|May 6, 2021
Overview and Update on Methods for Cargo Loading into Extracellular VesiclesYohan Han, Timothy W Jones, Saugata Dutta, et al.
Stroke Research and Treatment|August 23, 2014
Role of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonismTauheed Ishrat, Anna Kozak, Ahmed Alhusban, et al.
Pageof 14